Clinical factors associated with high <scp>PD</scp>‐<scp>L1</scp> expression in patients with early‐stage non‐small cell lung cancer
These results showed that plasma fibrinogen, smoking history, and SUVmax are predictors of high PD-L1 expression, providing a basis for identifying patients expected to benefit from neoadjuvant ICI treatment.
Authors
- Yasuhiro Tsutani (ORCID: https://orcid.org/0000-0001-8836-1027)
- Masato Chiba
- Junichi Soh (ORCID: https://orcid.org/0000-0001-8532-7915)
- Masaoki Ito (ORCID: https://orcid.org/0000-0001-7296-4624)
- Akira Hamada (ORCID: https://orcid.org/0000-0003-1689-9447)
- Masaki Shimoji
- Kenichi Suda (ORCID: https://orcid.org/0000-0002-0842-8832)
- Shuta Ohara (ORCID: https://orcid.org/0000-0002-9159-8743)
- Toshiki Takemoto
Institutions
- Osaka Metropolitan University (JP)
- Tokyo Metropolitan University (JP)
- Kindai University (JP)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2024-09-19
- DOI
- https://doi.org/10.1111/1759-7714.15453
- Citations
- 3
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- Japan Society for the Promotion of Science